Expert Insights: From animal to iPSC-derived models, a new era in preclinical evaluation
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease